Company CVAbout Beryl Drugs Ltd 
Beryl Drugs Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Beryl Drugs Limited, based in Indore, was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange. The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally. It offers I.V.
Company Coordinates
Company Details
133 Kanchan Bag , Indore Madhya Pradesh : 452001
Registrar Details
Adroit Corporate Services Pvt Ltd, 17-20 Jaferbhoy Industrial Estate , 1st Floor, Makwana Road, Marol Naka, Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 5.07 Cr
Number of Shares
50.72 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
21-Mar-2014
50.72
5.07
-59300
10
Forfeited Shares
21-Mar-2014
50.72
5.07
-59300
10
Forfeited Shares
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Sanjay Sethi (10.88%)
Highest Public shareholder
Samir Narendra Gupta (3.88%)
Individual Investors Holdings
68.71%
Board of Directors
Management
Designation
Remuneration
Sanjay Sethi
ED / MD / Promoter
21.0 lacs
Sudhir Sethi
Chairman & Non Executive Dir.
0
Abhinav Naik
Independent Non Exe. Director
40.0 k
Shreya Saraf
Independent Non Exe. Director
40.0 k
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Sales of Large & Small Volume Injection
14.91
97.49%
Scrap
0.38
2.51%
Sales of Large & Small Volume Injection
Sales of Large & Small Volume Injection
Scrap
Scrap
Stock DNARevenue and Profits:
Net Sales:
5 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
Pharmaceuticals & Biotechnology
INR 11 Cr (Micro Cap)
48.00
34
0.00%
0.34
2.42%
1.19
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
